Portuguese supplies spending sustained despite cost-cutting drive
This article was originally published in Clinica
Portugal's national health service (SNS) succeeded in containing its spending in 2007 at less than 3.1% above the previous year's - an increase of E244m ($362m). So reports the directorate-general for budgeting (DGO), citing provisional estimates that take the total to around E7.9bn. These feature a 2.2% increase in non-capital purchasing, which it attributed to "better practices in hospital provisioning and a reduction in the cost of medicines". In terms of financial management, despite an 8% rise in service delivery costs and a 23.3% increase in "investment subsidy", the DGO believes that 2007 ended with a budgetary surplus of around E110m.
You may also be interested in...
As part of its response to the coronavirus outbreak, the European association representing generic and biosimilar drug companies, Medicines for Europe, has set out a series of policy recommendations that it says could help to mitigate the possible risks to medicines supply.
Podcast: Living In China's Coronavirus Lockdown, Novartis and England's 'Public Health' Alliance; Biogen's Moment of Truth Approaches
Japan bioventure BioComo was set up around 10 years ago and has since been honing its technology platform. It is now preparing to move into the clinic with a novel vector for immuno-oncology and to raise new funds to support pipeline development.